Blood coagulation induced by Bothrops atrox venom: identification and properties of a factor X activator

Biochimie
H HofmannC Bon

Abstract

The coagulating activity of Bothrops atrox venom was investigated in vitro with purified fibrinogen, with normal plasma and with plasma deficient in various factors of the coagulation cascade. This study indicated that Bothrops atrox venom possesses a thrombin-like action caused by one or several serine proteases sensitive to DFP treatment, but that its clotting action is in fact mainly due to components insensitive to DFP which activate prothrombin and factor X (Stuart factor). We partially purified the DFP insensitive activator of factor X from Bothrops atrox venom and found it to be a protein of molecular weight 77,000. Analysis of the purified fraction by electrophoresis on polyacrylamide gel in the presence of SDS showed that it is mainly composed of one heavy polypeptide chain (65,000) and one light doublet (12 - 13,000). This activator is calcium-dependent and catalyzes in vitro the conversion of purified factor X into factor X alpha. By its molecular properties, it resembles the factor X activator from Vipera russellii venom rather than physiological activators.

References

Jan 1, 1977·Toxicon : Official Journal of the International Society on Toxinology·Y Furukawa, K Hayashi
Jun 1, 1977·Thrombosis Research·S NiewiarowskiK Stocker
Jan 1, 1976·Methods in Enzymology·K Stocker, G H Barlow
Mar 1, 1972·The Journal of Clinical Investigation·S NiewiarowskiJ F Mustard
May 1, 1970·Toxicon : Official Journal of the International Society on Toxinology·K W Denson, W E Rousseau
Oct 1, 1969·The American Journal of Medicine·H J WeissS Kochwa
Jul 1, 1967·British Journal of Haematology·M P Esnouf, G W Tunnah
Apr 30, 1937·The Journal of Experimental Medicine·H Eagle
Mar 20, 1937·The Journal of General Physiology·H Eagle, T N Harris

❮ Previous
Next ❯

Citations

Jan 1, 1989·Toxicon : Official Journal of the International Society on Toxinology·F ChavesL Cerdas
Jan 1, 1989·Toxicon : Official Journal of the International Society on Toxinology·A S Kamiguti, J L Cardoso
Aug 1, 1993·Toxicon : Official Journal of the International Society on Toxinology·T FaridM F el-Asmar
Jan 1, 1995·Toxicon : Official Journal of the International Society on Toxinology·M Samel, J Siigur
Jan 1, 1986·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·J M GutiérrezL Cerdas
Oct 12, 2000·Toxicon : Official Journal of the International Society on Toxinology·S Y ChoY S Kim
Oct 12, 2000·Toxicon : Official Journal of the International Society on Toxinology·Y S KohD S Kim
Aug 2, 2003·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Mari SamelJüri Siigur
Jul 25, 2000·British Journal of Pharmacology·C C WuC M Teng
Oct 22, 2013·Toxicon : Official Journal of the International Society on Toxinology·Liliane Maria Fernandes de OliveiraRaghuvir K Arni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.